Freed's Single-Doctor Scaling Challenge

This is the main limit of Freed's self serve playbook, it wins fast at the point where one doctor can swipe a card and start using it the same day, but growth gets harder once a clinic wants the tool connected to its EHR and approved for handling patient data. At that point the sale shifts from a doctor buying a productivity app to an organization running security review, signing a business associate agreement, and involving IT.

• Freed's core offer is built for instant adoption, a $99 per month subscription sold to individual clinicians, with note capture first and deeper workflows added later. That makes it easy to land solo and very small practices, but those accounts have few seats to expand inside.
  2 sacra 3 sacra
• Small group and mid sized practices are where the model changes. Once a scribe needs EHR integration, copy and paste is no longer enough, and each practice can sit on a different EHR with different data formats and approval steps. That creates a long tail of integration work and slows bottom up expansion.
  1 sacra 2 sacra
• The contrast with Abridge shows the tradeoff clearly. Abridge grew by tying itself to Epic and Athenahealth, reaching 60,000 plus clinicians across 100 plus health systems, while Freed grew quickly with individual doctors to 17,000 clinicians by March 2025. One path is lighter and faster, the other is heavier but scales through centralized buyers.
  2 sacra 3 sacra

The next phase is moving from a beloved single user tool into a system level workflow product. If Freed keeps adding pre charting, coding, and payments, it will need more formal integrations and sales motion, which pushes it toward the same organizational buying process that enterprise scribes already navigate.